<clinical_study>
  <!-- This xml conforms to an XML Schema at:
    https://clinicaltrials.gov/ct2/html/images/info/public.xsd -->
  <required_header>
    <download_date>ClinicalTrials.gov processed this data on July 28, 2020</download_date>
    <link_text>Link to the current ClinicalTrials.gov record.</link_text>
    <url>https://clinicaltrials.gov/show/NCT03902314</url>
  </required_header>
  <id_info>
    <org_study_id>014118</org_study_id>
    <nct_id>NCT03902314</nct_id>
  </id_info>
  <brief_title>Lidocaine Infusion for Pain Relief in Children Scheduled for Tonsillectomy and Adenoidectomy</brief_title>
  <official_title>Lidocaine Infusions for Children Undergoing Combined Tonsillectomy and Adenoidectomy: A Double-Blinded, Randomized, Placebo-Controlled Trial</official_title>
  <sponsors>
    <lead_sponsor>
      <agency>Rhode Island Hospital</agency>
      <agency_class>Other</agency_class>
    </lead_sponsor>
  </sponsors>
  <source>Rhode Island Hospital</source>
  <oversight_info>
    <is_fda_regulated_drug>Yes</is_fda_regulated_drug>
    <is_fda_regulated_device>No</is_fda_regulated_device>
    <is_us_export>No</is_us_export>
  </oversight_info>
  <brief_summary>
    <textblock>
      Lidocaine is widely available and is a very commonly used local anesthetic. When administered
      intravenously, lidocaine infusions have anti-inflammatory effects and have significantly
      decreased the reliance on opioid use for adequate pain management in adult abdominal and
      spine surgeries. A major advantage of lidocaine infusion is that it is not associated with a
      significant side effect profile.The role of lidocaine in pediatric acute perioperative pain
      remains limited.
    </textblock>
  </brief_summary>
  <detailed_description>
    <textblock>
      The aim of the study is to determine if using lidocaine continuously during anesthesia care
      will decrease post-operative pain for children having their tonsils and adenoids removed.
    </textblock>
  </detailed_description>
  <overall_status>Recruiting</overall_status>
  <start_date type="Actual">May 7, 2019</start_date>
  <completion_date type="Anticipated">July 2020</completion_date>
  <primary_completion_date type="Anticipated">April 2020</primary_completion_date>
  <phase>Phase 4</phase>
  <study_type>Interventional</study_type>
  <has_expanded_access>No</has_expanded_access>
  <study_design_info>
    <allocation>Randomized</allocation>
    <intervention_model>Parallel Assignment</intervention_model>
    <intervention_model_description>Enrolled patients will be randomly assigned into one of two intervention groups:
Group 1: systemic lidocaine infusion Group 2: normal saline infusion</intervention_model_description>
    <primary_purpose>Treatment</primary_purpose>
    <masking>Triple (Participant, Care Provider, Outcomes Assessor)</masking>
    <masking_description>Anesthesia care providers will be acquiring the study solution from the institution's pharmacy (lidocaine or saline) to administer perioperatively. The pharmacy will prepare the study solutions per randomization and label the solution as the study solution without reference to lidocaine or saline. Per protocol, the care providers will then administer the study solution as a weight based infusion.</masking_description>
  </study_design_info>
  <primary_outcome>
    <measure>Change in Pain Scores</measure>
    <time_frame>15 minute intervals in postanesthesia care unit; up to 120 minutes following surgery.</time_frame>
    <description>FLACC scale includes 5 categories (Face, Legs, Activity, Cry, Consolability) of pain behaviors scored from 0-2 to provide a total pain score ranging from 0 to 10 with higher numbers indicating greater or worse pain.</description>
  </primary_outcome>
  <secondary_outcome>
    <measure>Opioid consumption</measure>
    <time_frame>Total perioperative period: time in the operating room until time of discharge to home from the postoperative anesthesia care unit (PACU)</time_frame>
    <description>Morphine equivalents</description>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Emergence delirium scores</measure>
    <time_frame>5 minute intervals for the first 30 minutes in postanesthesia care unit, then every 15 minutes for an additional 90 minutes after surgery</time_frame>
    <description>Pediatric Anesthesia Emergence Delirium (PAED) scale to differentiate emergence delirium from postoperative pain. The scale includes 5 categories (eye contact, purposefulness of actions, awareness of surroundings, restlessness, inconsolable) each scored from 0 to 4 to provide a total score ranging from 0 to 20 with higher numbers being worse indicating that the emergence behaviors correlate better with emergence delirium.</description>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Parental satisfaction with the anesthetic</measure>
    <time_frame>Evaluated once on postoperative day 1 (or 24 hours after surgery)</time_frame>
    <description>Measured on a scale from 0 to 10, where 0 means very unsatisfied and 10 means very satisfied; higher numbers are better</description>
  </secondary_outcome>
  <number_of_arms>2</number_of_arms>
  <enrollment type="Anticipated">70</enrollment>
  <condition>Children, Only</condition>
  <condition>Tonsillar Hypertrophy</condition>
  <condition>Adenoid Hypertrophy</condition>
  <arm_group>
    <arm_group_label>Lidocaine</arm_group_label>
    <arm_group_type>Active Comparator</arm_group_type>
    <description>Lidocaine infusion at 2 mg/kg/hr will be started in the operating room and continue in the recovery period for 60 minutes.</description>
  </arm_group>
  <arm_group>
    <arm_group_label>Saline</arm_group_label>
    <arm_group_type>Placebo Comparator</arm_group_type>
    <description>Saline infusion at 2 mg/kg/hr will be started in the operating room and continue in the recovery period for 60 minutes.</description>
  </arm_group>
  <intervention>
    <intervention_type>Drug</intervention_type>
    <intervention_name>Lidocaine Iv</intervention_name>
    <description>Intravenous infusion</description>
    <arm_group_label>Lidocaine</arm_group_label>
  </intervention>
  <intervention>
    <intervention_type>Drug</intervention_type>
    <intervention_name>Saline Solution</intervention_name>
    <description>Intravenous infusion</description>
    <arm_group_label>Saline</arm_group_label>
  </intervention>
  <eligibility>
    <criteria>
      <textblock>
        Inclusion Criteria:

        - scheduled tonsillectomy and adenoidectomy with or without myringotomy/PE tubes at Hasbro
        Children's Hospital

        Exclusion Criteria:

          -  history of allergies to local anesthetics

          -  physical or developmental delays

          -  psychiatric illness

          -  current use of sedative or anticonvulsive medications

          -  use of premedication (oral/nasal)

          -  pre-existing cardiovascular, renal, or hepatic disease

          -  pre-existing cerebral or neuromuscular disease

          -  patient with personal or family history of malignant hyperthermia

          -  recent history of upper respiratory infection within last 7 days

          -  regular use of analgesic medications
      </textblock>
    </criteria>
    <gender>All</gender>
    <minimum_age>4 Years</minimum_age>
    <maximum_age>10 Years</maximum_age>
    <healthy_volunteers>No</healthy_volunteers>
  </eligibility>
  <overall_official>
    <last_name>Edward Suh, MD</last_name>
    <role>Principal Investigator</role>
    <affiliation>Lifespan</affiliation>
  </overall_official>
  <overall_contact>
    <last_name>Edward I Suh, MD</last_name>
    <phone>401-444-5172</phone>
    <email>esuh@lifespan.org</email>
  </overall_contact>
  <overall_contact_backup>
    <last_name>Mark Kendall, MD</last_name>
    <phone>401-444-4933</phone>
    <email>mark.kendall@lifespan.org</email>
  </overall_contact_backup>
  <location>
    <facility>
      <name>Hasbro Children's Hospital</name>
      <address>
        <city>Providence</city>
        <state>Rhode Island</state>
        <zip>02903</zip>
        <country>United States</country>
      </address>
    </facility>
    <status>Recruiting</status>
    <contact>
      <last_name>Edward I Suh, MD</last_name>
      <phone>401-444-5172</phone>
      <email>esuh@lifespan.org</email>
    </contact>
    <contact_backup>
      <last_name>Mark Kendall, MD</last_name>
      <phone>401-444-4933</phone>
      <email>mark.kendall@lifespan.org</email>
    </contact_backup>
    <investigator>
      <last_name>Edward I Suh, MD</last_name>
      <role>Principal Investigator</role>
    </investigator>
    <investigator>
      <last_name>Mark Kendall, MD</last_name>
      <role>Sub-Investigator</role>
    </investigator>
    <investigator>
      <last_name>Jan Groblewski, MD</last_name>
      <role>Sub-Investigator</role>
    </investigator>
  </location>
  <location_countries>
    <country>United States</country>
  </location_countries>
  <reference>
    <citation>Guntinas-Lichius O, Volk GF, Geissler K, Komann M, Meissner W. Pain after pediatric otorhinolaryngologic surgery: a prospective multi-center trial. Eur Arch Otorhinolaryngol. 2014 Jul;271(7):2049-60. doi: 10.1007/s00405-014-2914-9. Epub 2014 Feb 9.</citation>
    <PMID>24510234</PMID>
  </reference>
  <reference>
    <citation>Howard D, Davis KF, Phillips E, Ryan E, Scalford D, Flynn-Roth R, Ely E. Pain management for pediatric tonsillectomy: an integrative review through the perioperative and home experience. J Spec Pediatr Nurs. 2014 Jan;19(1):5-16. doi: 10.1111/jspn.12048. Epub 2013 Aug 21. Review.</citation>
    <PMID>24393224</PMID>
  </reference>
  <reference>
    <citation>Koppert W, Ostermeier N, Sittl R, Weidner C, Schmelz M. Low-dose lidocaine reduces secondary hyperalgesia by a central mode of action. Pain. 2000 Mar;85(1-2):217-24.</citation>
    <PMID>10692621</PMID>
  </reference>
  <reference>
    <citation>Vigneault L, Turgeon AF, Côté D, Lauzier F, Zarychanski R, Moore L, McIntyre LA, Nicole PC, Fergusson DA. Perioperative intravenous lidocaine infusion for postoperative pain control: a meta-analysis of randomized controlled trials. Can J Anaesth. 2011 Jan;58(1):22-37. doi: 10.1007/s12630-010-9407-0. Review.</citation>
    <PMID>21061107</PMID>
  </reference>
  <verification_date>May 2019</verification_date>
  <study_first_submitted>March 27, 2019</study_first_submitted>
  <study_first_submitted_qc>April 2, 2019</study_first_submitted_qc>
  <study_first_posted type="Actual">April 4, 2019</study_first_posted>
  <last_update_submitted>May 10, 2019</last_update_submitted>
  <last_update_submitted_qc>May 10, 2019</last_update_submitted_qc>
  <last_update_posted type="Actual">May 14, 2019</last_update_posted>
  <responsible_party>
    <responsible_party_type>Principal Investigator</responsible_party_type>
    <investigator_affiliation>Rhode Island Hospital</investigator_affiliation>
    <investigator_full_name>Edward Suh</investigator_full_name>
    <investigator_title>Principal Investigator; Clinical Instructor</investigator_title>
  </responsible_party>
  <keyword>Lidocaine</keyword>
  <keyword>Tonsillectomy and Adenoidectomy</keyword>
  <keyword>Pain</keyword>
  <condition_browse>
    <!-- CAUTION:  The following MeSH terms are assigned with an imperfect algorithm            -->
    <mesh_term>Hypertrophy</mesh_term>
  </condition_browse>
  <intervention_browse>
    <!-- CAUTION:  The following MeSH terms are assigned with an imperfect algorithm            -->
    <mesh_term>Lidocaine</mesh_term>
  </intervention_browse>
  <patient_data>
    <sharing_ipd>No</sharing_ipd>
  </patient_data>
  <!-- Results have not yet been posted for this study                                          -->
</clinical_study>

